Publications by authors named "A P Early"

The malaria parasites Plasmodium falciparum and Plasmodium vivax differ in key biological processes and associated clinical effects, but consequences on population-level transmission dynamics are difficult to predict. This co-endemic malaria study from Guyana details important epidemiological contrasts between the species by coupling population genomics (1396 spatiotemporally matched parasite genomes, primarily from 2020-21) with sociodemographic analysis (nationwide patient census from 2019). We describe how P.

View Article and Find Full Text PDF

Antimalarial resistance in is a public health problem in the fight against malaria in Ecuador. Characterizing the molecular epidemiology of drug resistance genes helps to understand the emergence and spread of resistant parasites. In this study, the effects of drug pressure and human migration on antimalarial resistance in were evaluated.

View Article and Find Full Text PDF

Background: The ADAURA trial confirmed adjuvant Osimertinib's efficacy in EGFR-mutated Non-small-cell lung cancer (NSCLC), yet the limited mature overall survival (OS) data at approval poses a challenge. This study explores patient preferences in the absence of complete OS information, hypothesizing that disease-free survival (DFS) benefit alone may influence adjuvant Osimertinib pursuit.

Methods: At Roswell Park Comprehensive Cancer Center (Jan-Dec 2021), patients assessed for adjuvant therapy received a survey probing OS and DFS preferences.

View Article and Find Full Text PDF

Plasmodium parasites, the causal agents of malaria, are eukaryotic organisms that obligately undergo sexual recombination within mosquitoes. In low transmission settings, parasites recombine with themselves, and the clonal lineage is propagated rather than broken up by outcrossing. We investigated whether stochastic/neutral factors drive the persistence and abundance of Plasmodium falciparum clonal lineages in Guyana, a country with relatively low malaria transmission, but the only setting in the Americas in which an important artemisinin resistance mutation (pfk13 C580Y) has been observed.

View Article and Find Full Text PDF
Article Synopsis
  • The RTS,S/AS01 malaria vaccine was tested for its effectiveness in a study involving 1,500 children aged 5-17 months in Ghana and Kenya, focusing on different dosing regimens.
  • Four different groups received the vaccine in varying full and fractional doses, while a control group got a rabies vaccine.
  • Results showed all RTS,S/AS01 regimens provided similar vaccine efficacy (25-43%) against new malaria infections, significantly reducing the number of infections over a 20-month follow-up period.
View Article and Find Full Text PDF